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Introduction. Clear cell basal cell carcinoma (BCC) is an uncommon and unusual variant of BCC, which is characterized by
a variable component of clear cells. The pathogenesis of this histological variant and its clinical signiﬁcance has not been clariﬁed.
Diﬀerentiation of this uncommonvariant of BCC from other clearcell tumorsis important forthetreatment. Case Presentation.A
65-year-old malepresented witha 0.9cmdome-shaped lesiononhisupper chest. Ashavebiopsyrevealed adermalbasaloidtumor
that comprised nests with a peripheral palisading pattern, retraction artifacts, and striking clear cell changes. Histopathologic
examination,alongwith ﬁndings from immunohistochemicalstudies and special stainingof the clear cells, supports the diagnosis
of clear cell basal cell carcinoma. Conclusion. Clear cell BCC is a rare and unusual variant of BCC. The underlying pathogenesis of
this subtype is unclear; however, accurate identiﬁcation may aﬀect treatment and prognosis.
1.Introduction
Basal cell carcinoma is the most common cutaneous malig-
nant tumor directly related to sunlight and UV radiation
exposure. A number of histopathological subtypes of basal
cell carcinoma have been deﬁned. Among these subtypes,
clear cell basal cell carcinoma is a rare variant composed of
tumor cells with prominent cytoplasmic vacuoles or signet
ring morphology. The pathogenesis of this variant, however,
remains unclear. Distinguishing among basal cell variants
as well as diﬀerentiating it from other clear cell tumors is
important because treatment and prognosis of each may
vary.
2.CasePresentation
A 65-year-old male presented with a 0.9cm dome-shaped
dark lesion on his upper chest. The clinical impression
was basal cell carcinoma versus recurrent dysplastic nevus.
The shave biopsy specimen showed a dermal tumor that
comprised nests of basaloid cells with a peripheral pal-
isading pattern and retraction artifacts (Figures 1 and 2).
The basaloid cells were mitotically active, and apoptotic
bodies were noted. The basaloid neoplasm manifested all
features of ordinary basal cell carcinoma. However, striking
clear cell changes were observed in the center of large
nests (Figure 2). The clear cells were striking in appearance
with a single large vacuole in their cytoplasm and a dark,
condensed nucleus at the periphery. There were no clear
cells with foamy-bubbly cytoplasm or starry nuclei; when
present, this ﬁnding is typical of sebaceous cells. There
were no clear pagetoid cells in the overlying epidermis. PAS
staining was positive for the presence of glycogen (Figures
3 and 4), but no mucin was identiﬁed by mucicarmine
stain. Immunohistochemical studies showed positive stain-
ing for EMA (Figure 5), Bcl-2 (Figure 6), CK5/6, and high
molecular weight keratin but not for S 100 or vimentin.
Ki-67 staining of the clear cells (Figure 7)w a sn e g a t i v e
compared to the positive staining of a typical nodular basal
cell carcinoma (Figure 8), suggesting a lack of prolifera-
tive activity. Additionally, no mitotic ﬁgures are seen on
histopathologic examination of the clear cell components.
The basaloid cells and the clear cells shared a similar
p53 mutation pattern (Figure 9). Findings consistent with2 Pathology Research International
Figure 1: Low-power examination revealed a dermal basaloid
tumor that comprised nests with clear cell changes present.
Figure2:Theclearcellsarepleomorphicwithasinglelargevacuole
in their cytoplasm and a peripheral condensed hyperchromatic
nucleus.
a clear cell basal cell carcinoma include morphology (typical
nodular basal cell carcinoma pattern with central vacuolated
cells without any foamy-bubbly cytoplasm), positive cyto-
plasmic glycogen, strongly positive Bcl-2 protein, positive
CK 5/6, and positive high molecular weight keratin on
immunostaining.
The lesion was completely excised with clear margins.
Three years later, the patient remains free of any recurrence.
3.Discussion
Basal cell carcinoma (BCC) is the most common skin
cancer, accounting for approximately 80% of nonmelanoma
skin cancers. BCC usually occurs in sun exposed areas of
the skin, most often the head and neck (80%), followed
by the trunk (15%), and extremities [1]. Risk factors for
developing BCC include exposure to ultraviolet radiation,
a fair complexion, and immunosuppression. The clinical
presentation can be quite variable, but lesions are typi-
cally described as shiny, pearly papules or nodules with
a rolled border that may exhibit crusting, ulceration, or
bleeding.
BCC is thought to arise from pluripotential cells in the
basal layerofthe epidermis that are capableof diﬀerentiating
into hair, sebaceous glands, or sweat glands. Perhaps
as a consequence, there is considerable histopathologic
variation among basal cell tumors, and several subtypes
Figure 3:PASwithoutdiastasestainshowspositivecytoplasmicred
material (glycogen) in the clear cells.
Figure 4: PAS with diastase stain is negative suggesting presence of
glycogen but not mucin in the clear cells.
Figure 5 :T h ec l e a rc e l l sa r es t r o n g l yp o s i t i v ew i t hE M Ai m m u n o s -
taining.
have been described. Sexton et al. reviewed 1039 cases of
BCC and found the most common subtypes to be mixed
(38.6%), nodular (21%), superﬁcial (17.4%), and micron-
odular (14.5%) [2]. In addition, there are several rare
variants, including basosquamous, morpheaform, keratotic,
granular cell, adamantoid, and clear cell type. The utilityPathology Research International 3
Figure 6: The peripheral basal cells are strongly positive with Bcl-2
protein immunostaining.The central clear cells are focally positive.
Figure 7: Ki-67 stain demonstrates negative nuclear staining in the
clear cells in the center compared to the positive peripheral basal
cells.
in classifying BCC subtypes is that there appears to be
a correlation between the histologic subtype and the clinical
behavior. Micronodular, inﬁltrative, basosquamous, and
morpheaform subtypes are more aggressive, while nodular
and superﬁcial types are less aggressive [3].
Clear cell basal cell carcinoma was ﬁrst described by
Barr and Williamson in 1984 [4]. A review of the literature
to date reveals a total of 32 reported cases since that ﬁrst
description. Histochemical observations between cases have
beeninconsistent.PASstainingwithandwithoutdiastasehas
been positive for glycogen in some cases [4–6]b u tn o ti n
others [7–10]. One report noted the presence of sialomucin
deposition [6] constituting about 3% of the reported cases.
Electron microscopic studies have also been variable, as
some have observed the large intracellular vacuoles to be
membrane bound [10, 11], while others have not [5, 7, 9].
The diﬀerential diagnosis of clear cell basal cell carci-
noma includessebaceouscarcinoma, clearcell squamouscell
carcinoma, eccrine porocarcinoma, hidroadenocarcinoma,
trichilemmal carcinoma, clearcellmelanoma, andmetastatic
clear cell renal carcinoma. Sebaceous carcinoma cells with
“foamy-bubbly” cytoplasm are positive for lipid on staining
with Oil Red O or Sudan IV on frozen tissue and are
Figure 8: In contrast, a typical nodular basal cell carcinoma shows
Ki-67-stained nuclei throughout the entire tumor nodule.
Figure 9: The basaloid cells and clear cells share a similar p53
nuclear mutationpattern.
positive with EMA and CAM 5.2 immunostaining. A small
amount of cytoplasmic glycogen may be present. Clear cell
squamous cell carcinoma is characterized by evidence of
hydropic change of the neoplastic cells with accumulation of
intracellular ﬂuid and shows areas of squamous diﬀerenti-
ation with foci of keratinization and keratin pearls. Unlike
other cutaneous clear cell neoplasms, the accumulated ﬂuid
does not stain for glycogen,lipid, or mucin. The clearcells of
eccrine porocarcinoma contain glycogen shown by diastase-
resistant PAS positive cytoplasm. Moreover, they are positive
with CEA and EMA immunostaining. The clear cells seen in
eccrine hidroadenocarcinoma contain diastase-resistant PAS
positive cytoplasmic glycogen. They are also positive with
CEA and S-100 protein immunostaining. In contrast, clear
cells in trichilemmal carcinoma have abundant glycogen but
exhibit CEA and EMA negativity. The clear cell subtype
of melanoma, also known as balloon cell melanoma, is
usually S-100 and HMB-45 positive. Finally, the clear cells
of metastatic renal cell carcinoma contain lipid (stained with
Oil Red O) and glycogen but are negative for CEA and S-100
protein.
Because the clear cells of clear cell BCC stain positive for
glycogen,thepathogenesiswasinitiallysuggestedtobedueto4 Pathology Research International
trichilemmal diﬀerentiation[4].Subsequenthypothesis have
suggested that the large, clear membrane-bound vacuoles
are phagolysosomes containing degradation products of
intracellular organelles [7, 10]. However, the underlying
mechanisms responsible for this histologic subtype of BCC
are unknown.
4.Conclusion
Clear cell BCC is a rare and unusual variant of BCC. The
underlying pathogenesis, clinical eﬀect on treatment, and
prognosis of this subtype remain unclear.
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